Erin McCallister serves as senior editor for BioCentury where she is responsible for covering emerging issues in market access and reimbursement as well as innovative product development strategies, including novel clinical trial designs, patient-centered drug development and new methods for making R&D more efficient. Prior to joining BioCentury in 2008, Erin served as a program officer for the Great Lakes Protection Fund and a biologist at Dow AgroSciences. She holds an M. Sc. in environmental science and policy from the University of Chicago and a B.S. in biology from Purdue University.